Drugs and Devices

FDA allows marketing of consumer genetic tests

On April 6, the U.S. Food and Drug Administration (FDA) announced it was allowing marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer genetic tests that the FDA as authorized. Read more 


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares